Market

Increasing product offerings, to accelerate growth opportunities, drives M&A activity in November, according to Datamonitor’s…

Next year’s event to be held from December 3-5, 2013

The EU parliament has rejected the Anti-Countefeiting Trade Agreement (ACTA) but there are other similar moves to restrict free…

Viveka Roychowdhury reports on the successful right sizing of strategies by both pharma MNCs and their Indian counterparts

With India's DBT committing 30 per cent of its budget to PPPs, will these fund an ecosystem for small and medium sized companies…

Indian pharmaceutical companies in order mark its presence in the international markets, need to focus on regions having high…

With World Environment Day fast approaching, Usha Sharma analyses the pharma industry's measures to preserve the environment and…

India is an attractive destination for biotech enterpreneurs from across the globe and local companies are prising open this door…

After witnessing watershed deals in the past few years, the M&A scenario in India seems to be MIA: Missing in Action. However,…

The Government of India recently banned the use of serology-based test kits for diagnosis of tuberculosis. But this will translate…

Recently, the Central Drugs Standard Control Organisation (CDSCO) called for recommendations and suggestions on its draft…

Rephrasing a common proverb, a lean compromise is better than a fat disguise. However, people of India do not seem to have taken…